GAP NARROWING BETWEEN FACIAL FILLERS

Article

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.